Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,118 across all filing types
Latest filing 2024-01-03 Share Issue/Capital Cha…
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Notification regarding unquoted securities - MYX 6 pages 27.6KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Notification of Issue, Conversion or Payment up of Unquoted Equity Securities' and details the issuance and conversion of unquoted options and convertible securities into ordinary fully paid shares. It includes specifics such as the number of securities issued, dates of conversion, and whether the securities were issued under an employee incentive scheme. The document is a formal announcement of securities issuance and conversion activity, which aligns with the category of Share Issue/Capital Change filings. It is not a full financial report, earnings release, or management discussion, but rather a notification about changes in the company's capital structure. Therefore, the appropriate classification is 'SHA' for Share Issue/Capital Change.
2024-01-03 English
Mayne Pharma to present at JP Morgan Healthcare Conference 1
Investor Presentation Classification · 85% confidence The document is an ASX announcement about Mayne Pharma's CEO presenting at the 42nd Annual J.P. Morgan Healthcare Conference. It provides details about the date, time, webcast, and contact information. There is no financial data, no detailed presentation content, nor any report attached or referenced as being published. The document is a brief announcement of an upcoming investor presentation event, not the presentation itself or a financial report. Therefore, it fits best as an Investor Presentation (IP) announcement category, as it relates to a presentation for investors focusing on financials, strategy, and market position, even though the actual presentation content is not included here. Given the short length and nature of the announcement, confidence is high but not absolute since the actual presentation is not included, only the announcement of it.
2024-01-01 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification of a daily buy-back of shares by Mayne Pharma Group Limited. It includes specifics such as the number of securities bought back, prices paid, dates, broker information, and regulatory compliance details related to the buy-back. The content is focused on the company's repurchase of its own shares, which aligns with the category of Transaction in Own Shares. There is no indication that this is a report or announcement of a report, nor does it fit other categories like capital raising or management changes. Therefore, the appropriate classification is POS (Transaction in Own Shares). The document length and detail support a high confidence in this classification.
2023-12-21 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification of a daily buy-back of shares by Mayne Pharma Group Limited. It includes specifics such as the number of securities bought back, prices paid, dates, broker information, and regulatory compliance details related to the on-market buy-back program. This type of document is a report on the company's repurchase of its own shares, which fits the category of 'Transaction in Own Shares' (POS). It is not an announcement of a report, nor is it a financial report or regulatory filing unrelated to share transactions. Therefore, the correct classification is POS with high confidence.
2023-12-20 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification about a company's share buy-back activity, including daily updates on the number of securities bought back, prices paid, broker information, and regulatory compliance details. It specifically mentions 'Notification of buy-back' and 'Daily buy-back notification' multiple times, indicating it is a report on the company's repurchase of its own shares. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. The document is not an announcement of a report, nor is it a general regulatory filing or other report type. Therefore, the correct classification is POS with high confidence.
2023-12-19 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification of a daily buy-back of shares by Mayne Pharma Group Limited. It includes specifics such as the number of securities bought back, prices paid, dates, broker information, and regulatory compliance details related to the on-market buy-back program. There is no indication that this is a full financial report, earnings release, or any other type of report. Instead, it is a formal announcement of the company's share repurchase activity. According to the filing definitions, such documents fall under 'Transaction in Own Shares' (POS). The document length and content confirm it is not a brief announcement or a report publication notice but a substantive update on share buy-back activity.
2023-12-18 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.